Drugs that contain Testosterone Enanthate
1. Xyosted (autoinjector) patents expiration
XYOSTED (AUTOINJECTOR)'s oppositions filed in EPO
Can you believe XYOSTED (AUTOINJECTOR) received compensation for the extended wait time during the regulatory approval process?
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US10478560 | ANTARES PHARMA INC | Prefilled syringe injector |
Jan, 2026
(2 years from now) | |
| US11446441 | ANTARES PHARMA INC | Prefilled syringe injector |
Jan, 2026
(2 years from now) | |
| US8562564 | ANTARES PHARMA INC | Prefilled syringe jet injector |
Jan, 2026
(2 years from now) | |
| US9180259 | ANTARES PHARMA INC | Prefilled syringe jet injector |
Jan, 2026
(2 years from now) | |
| US9629959 | ANTARES PHARMA INC | Prefilled syringe jet injector |
Jan, 2026
(2 years from now) | |
| US9533102 | ANTARES PHARMA INC | Prefilled syringe jet injector |
Jan, 2026
(2 years from now) | |
| US8021335 | ANTARES PHARMA INC | Prefilled syringe jet injector |
Oct, 2026
(2 years from now) | |
| US11497753 | ANTARES PHARMA INC | Hazardous agent injection system |
Mar, 2030
(6 years from now) | |
| US10279131 | ANTARES PHARMA INC | Injection device with cammed RAM assembly |
Jul, 2031
(7 years from now) | |
| US11446440 | ANTARES PHARMA INC | Needle assisted injection device having reduced trigger force |
Aug, 2031
(7 years from now) | |
| US10905827 | ANTARES PHARMA INC | Injection device with cammed ram assembly |
Aug, 2031
(7 years from now) | |
| US10357609 | ANTARES PHARMA INC | Needle assisted jet injection device having reduced trigger force |
Aug, 2031
(7 years from now) | |
| US10821072 | ANTARES PHARMA INC | Needle assisted jet injection administration of testosterone compositions |
Jun, 2033
(9 years from now) | |
| US10881798 | ANTARES PHARMA INC | Needle assisted injection device having reduced trigger force |
Feb, 2034
(10 years from now) | |
| US11771646 | ANTARES PHARMA INC | Needle assisted jet injection administration of testosterone compositions |
Apr, 2034
(10 years from now) | |
| US11160751 | ANTARES PHARMA INC | Hematocrit modulation through needle assisted jet injection of testosterone |
Oct, 2034
(10 years from now) | |
| US10912782 | ANTARES PHARMA INC | Needle assisted injection administration of testosterone compositions |
Feb, 2035
(11 years from now) | |
| US10238662 | ANTARES PHARMA INC | Needle assisted jet injection administration of testosterone compositions |
Feb, 2035
(11 years from now) | |
| US11191908 | ANTARES PHARMA INC | Syringe shock absorber for use in an injection device |
Oct, 2035
(11 years from now) | |
| US9744302 | ANTARES PHARMA INC | Needle assisted jet injection device having reduced trigger force |
Nov, 2035
(11 years from now) | |
| US9950125 | ANTARES PHARMA INC | Needle assisted jet injection administration of testosterone compositions |
Sep, 2036
(12 years from now) | |
| US10646495 | ANTARES PHARMA INC | Testosterone ester triglyceride formulations |
Aug, 2038
(14 years from now) | |
Market Authorisation Date: 28 September, 2018
Treatment: Method of administering testosterone enanthate subcutaneously
Dosage: SOLUTION;SUBCUTANEOUS
More Information on Dosage
XYOSTED (AUTOINJECTOR) family patents
